Advertisement
UK markets closed
  • FTSE 100

    8,433.76
    +52.41 (+0.63%)
     
  • FTSE 250

    20,645.38
    +114.08 (+0.56%)
     
  • AIM

    789.87
    +6.17 (+0.79%)
     
  • GBP/EUR

    1.1622
    +0.0011 (+0.09%)
     
  • GBP/USD

    1.2525
    +0.0001 (+0.01%)
     
  • Bitcoin GBP

    48,527.72
    -1,484.52 (-2.97%)
     
  • CMC Crypto 200

    1,256.56
    -101.45 (-7.22%)
     
  • S&P 500

    5,222.68
    +8.60 (+0.16%)
     
  • DOW

    39,512.84
    +125.08 (+0.32%)
     
  • CRUDE OIL

    78.20
    -1.06 (-1.34%)
     
  • GOLD FUTURES

    2,366.90
    +26.60 (+1.14%)
     
  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     
  • HANG SENG

    18,963.68
    +425.87 (+2.30%)
     
  • DAX

    18,772.85
    +86.25 (+0.46%)
     
  • CAC 40

    8,219.14
    +31.49 (+0.38%)
     

Bayer hires law firm to investigate Monsanto stakeholder file issue

FILE PHOTO: Logo of Bayer AG is pictured at the annual results news conference of the German drugmaker in Leverkusen, Germany February 27, 2019. REUTERS/Wolfgang Rattay/File Photo (Reuters)

By Patricia Weiss and Ludwig Burger

FRANKFURT (Reuters) - Bayer said on Sunday it was hiring an external law firm to investigate French media complaints that Monsanto, the U.S. seed maker it took over last year, had compiled a file of influential personalities.

The German life sciences and pharmaceuticals group said that, following an internal review, it understood that this initiative had raised concerns and criticism.

"This is not the way Bayer seeks dialogue with society and stakeholders. We apologise for this behaviour," Bayer said in a statement. It added, however, that there was no indication that compiling the lists was illegal.

ADVERTISEMENT

French prosecutors opened an inquiry on Friday after newspaper Le Monde filed a complaint alleging that Monsanto had compiled a file of 200 names, including journalists and lawmakers, in the hope of influencing their positions on pesticides.

The French investigation is the latest fallout from Bayer's $63 billion (48.49 billion pounds) takeover of Monsanto. It already faces potentially heavy costs from U.S. class-action lawsuits in which plaintiffs argue that its Roundup weedkiller causes cancer.

Bayer shares have shed more than 40 percent since a first adverse U.S. judgment on Roundup last August, leaving the company with a market capitalisation smaller than the price it paid for Monsanto.

Shareholders delivered a rare rebuke to CEO Werner Baumann's management team at Bayer's annual general meeting last month, with a majority voting against ratifying the executive board's business conduct in 2018.

Commenting on the French allegations, Bayer said its law firm would inform all of the individuals on the Monsanto list about the information collected about them. Bayer would also "fully support" the French prosecutor's investigation.

Matthias Berninger, Bayer's new head of public and government affairs, would evaluate the matter internally and assess the behaviour of people involved, both inside and outside the company.

"Our highest priority is to create transparency," Bayer said, adding that the Monsanto manager responsible for the issue had left the company soon after the takeover.

"Bayer stands for openness and fair dealings with all interest groups," it added.

"We do not tolerate unethical behaviour in our company. Of course, this also applies to data protection regulations in all jurisdictions in which we operate."

(Writing by Douglas Busvine; Editing by Keith Weir)